382 related articles for article (PubMed ID: 26177645)
1. A New Era of Immunotherapy in Prostate Cancer.
Pizzola C; Rizvi SM; Joshi M
Curr Mol Pharmacol; 2016; 9(3):217-225. PubMed ID: 26177645
[TBL] [Abstract][Full Text] [Related]
2. Sipuleucel-T and immunotherapy in the treatment of prostate cancer.
Dawson NA; Roesch EE
Expert Opin Biol Ther; 2014 May; 14(5):709-19. PubMed ID: 24620782
[TBL] [Abstract][Full Text] [Related]
3. Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon.
Drugs R D; 2006; 7(3):197-201. PubMed ID: 16752945
[TBL] [Abstract][Full Text] [Related]
4. Combining immunotherapies for the treatment of prostate cancer.
Redman JM; Gulley JL; Madan RA
Urol Oncol; 2017 Dec; 35(12):694-700. PubMed ID: 29146441
[TBL] [Abstract][Full Text] [Related]
5. Beyond sipuleucel-T: immune approaches to treating prostate cancer.
Cheng ML; Fong L
Curr Treat Options Oncol; 2014 Mar; 15(1):115-26. PubMed ID: 24402184
[TBL] [Abstract][Full Text] [Related]
6. Molecular insights into the development of T cell-based immunotherapy for prostate cancer.
Dong B; Minze LJ; Xue W; Chen W
Expert Rev Clin Immunol; 2014 Nov; 10(11):1547-57. PubMed ID: 25259804
[TBL] [Abstract][Full Text] [Related]
7. Practical guide to immunotherapy in castration resistant prostate cancer: the use of sipuleucel-T immunotherapy.
Gomella LG; Gelpi-Hammerschmidt F; Kundavram C
Can J Urol; 2014 Apr; 21(2 Supp 1):48-56. PubMed ID: 24775724
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for Prostate Cancer: Where Do We Go From Here?-PART 1: Prostate Cancer Vaccines.
Patel A; Fong L
Oncology (Williston Park); 2018 Mar; 32(3):112-20. PubMed ID: 29548065
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy in treatment of metastatic prostate cancer: An approach to circumvent immunosuppressive tumor microenvironment.
Sun BL
Prostate; 2021 Nov; 81(15):1125-1134. PubMed ID: 34435699
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for prostate cancer: recent developments and future challenges.
Schweizer MT; Drake CG
Cancer Metastasis Rev; 2014 Sep; 33(2-3):641-55. PubMed ID: 24477411
[TBL] [Abstract][Full Text] [Related]
11. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
Ă–zdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
[TBL] [Abstract][Full Text] [Related]
12. Is There a Role for Immunotherapy in Prostate Cancer?
Rizzo A; Mollica V; Cimadamore A; Santoni M; Scarpelli M; Giunchi F; Cheng L; Lopez-Beltran A; Fiorentino M; Montironi R; Massari F
Cells; 2020 Sep; 9(9):. PubMed ID: 32911806
[TBL] [Abstract][Full Text] [Related]
13. Combining immunological and androgen-directed approaches: an emerging concept in prostate cancer immunotherapy.
Antonarakis ES; Drake CG
Curr Opin Oncol; 2012 May; 24(3):258-65. PubMed ID: 22410456
[TBL] [Abstract][Full Text] [Related]
14. Integration of immunotherapy into the management of advanced prostate cancer.
Kantoff P; Higano CS
Urol Oncol; 2012; 30(5 Suppl):S41-7. PubMed ID: 23040162
[TBL] [Abstract][Full Text] [Related]
15. Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer.
Sims RB
Vaccine; 2012 Jun; 30(29):4394-7. PubMed ID: 22122856
[TBL] [Abstract][Full Text] [Related]
16. Immune-based therapies for metastatic prostate cancer: an update.
Hossain MK; Nahar K; Donkor O; Apostolopoulos V
Immunotherapy; 2018 Feb; 10(4):283-298. PubMed ID: 29421982
[TBL] [Abstract][Full Text] [Related]
17. The targeting of indoleamine 2,3 dioxygenase -mediated immune escape in cancer.
Iversen TZ; Andersen MH; Svane IM
Basic Clin Pharmacol Toxicol; 2015 Jan; 116(1):19-24. PubMed ID: 25207460
[TBL] [Abstract][Full Text] [Related]
18. Evolving Role of Immunotherapy in Metastatic Castration Refractory Prostate Cancer.
Rathi N; McFarland TR; Nussenzveig R; Agarwal N; Swami U
Drugs; 2021 Feb; 81(2):191-206. PubMed ID: 33369720
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy in Prostate Cancer: Teaching an Old Dog New Tricks.
Comiskey MC; Dallos MC; Drake CG
Curr Oncol Rep; 2018 Aug; 20(9):75. PubMed ID: 30120592
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy and therapeutic vaccines in prostate cancer: an update on current strategies and clinical implications.
Singh BH; Gulley JL
Asian J Androl; 2014; 16(3):364-71. PubMed ID: 24435055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]